Percutaneous Radiofrequency Thermal Ablation of Primary and Metastatic Hepatic Tumors: Current Concepts and Review of the Literature

 

 Buy Article Permissions and Reprints

ABSTRACT

The liver is a common site for primary malignancy and hematogenous metastasis. Although surgical resection of primary or metastatic hepatic tumors is generally regarded as first-line therapy, the majority of patients with hepatic malignancy have disease that is not amenable to surgical resection because of tumor location, poor hepatic reserve, or medical comorbidities. This has led to significant interest in the development of nonsurgical image-guided therapies, including radiofrequency ablation (RFA). RFA is appealing as a minimally invasive therapy that may be performed on an outpatient basis. It enables ablation of an area 3 to 5 cm in diameter, with relatively low morbidity and mortality rates. The results concerning the use of percutaneous RFA in the treatment of hepatocellular carcinoma, colorectal metastases, and other hepatic metastases are reviewed in this article. Clinical and technical considerations and complications are also discussed.

REFERENCES

• 1 Bentrem D J, DeMatteo R P, Blumgart L H. Surgical therapy for metastatic disease to the liver.  Annu Rev Med. 2005;  56 139-156
  CrossrefPubMedGoogle Scholar
• 2 Curley S A, Marra P, Beaty K et al.. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients.  Ann Surg. 2004;  239 450-458
  CrossrefPubMedGoogle Scholar
• 3 Farmer D G, Rosve M H, Shaked A et al.. Current treatment modalities for hepatocellular carcinomas.  Ann Surg. 1994;  219 236-247
  PubMedGoogle Scholar
• 4 Fong Y, Blumgart L H, Cohen A M. Surgical treatment of colorectal metastases to the liver.  CA Cancer J Clin. 1995;  45 50-62
  PubMedGoogle Scholar
• 5 Fong Y, Kemedy N, Paty P et al.. Treatment of colorectal cancer: hepatic metastases.  Semin Surg Oncol. 1996;  12 219-252
  CrossrefPubMedGoogle Scholar
• 6 Franco D, Capussotti L, Smadja C et al.. Resection of hepatocellular carcinoma: results in 72 European patients with cirrhosis.  Gastroenterology. 1990;  98 733-738
  PubMedGoogle Scholar
• 7 Bismuth H, Majno P E. Hepatobiliary surgery.  J Hepatol. 2000;  32 208-224
  PubMedGoogle Scholar
• 8 Calvet X, Bruix J, Bru C et al.. Natural history of hepatocellular carcinoma in Spain: five year's experience in 249 cases.  J Hepatol. 1990;  10 311-317
  CrossrefPubMedGoogle Scholar
• 9 Ikeda K, Saitoh S, Koida I et al.. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.  Hepatology. 1993;  18 47-53
  CrossrefPubMedGoogle Scholar
• 10 Rhim H, Goldberg S N, Dodd G D et al.. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors.  Radiographics. 2001;  21 S17-S39
  PubMedGoogle Scholar
• 11 Gillams A R. The use of radiofrequency in cancer.  Br J Cancer. 2005;  92 1825-1829
  CrossrefPubMedGoogle Scholar
• 12 Tateishi R, Shiina S, Teratani T et al.. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases.  Cancer. 2005;  103 1201-1209
  CrossrefPubMedGoogle Scholar
• 13 Parikh A A, Curley S A, Fornage B D et al.. RFA of hepatic metastases.  Semin Oncol. 2002;  29 168-182
  PubMedGoogle Scholar
• 14 White T J, Roy-Choudhury S H, Breen D J et al.. Percutaneous radiofrequency ablation of colorectal hepatic metastases: initial experience.  Dig Surg. 2003;  21 314-320
  PubMedGoogle Scholar
• 15 Choi D, Lim H K, Kim M J et al.. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinoma: frequency and risk factors.  AJR Am J Roentgenol. 2005;  184 1860-1867
  CrossrefPubMedGoogle Scholar
• 16 Dupuy D E, Goldberg S N. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II.  J Vasc Interv Radiol. 2001;  12 1135-1148
  CrossrefPubMedGoogle Scholar
• 17 Rossi S, Garbagnati F, Lencioni R et al.. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.  Radiology. 2000;  217 119-126
  CrossrefPubMedGoogle Scholar
• 18 Choi D, Lim H K, Kim M J et al.. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract.  AJR Am J Roentgenol. 2004;  183 1417-1424
  PubMedGoogle Scholar
• 19 Yamakado K, Nakatsuka A, Akeboshi M et al.. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition.  J Vasc Interv Radiol. 2003;  14 1183-1186
  CrossrefPubMedGoogle Scholar
• 20 Chopra S, Dodd G D, Chanin M P et al.. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety.  AJR Am J Roentgenol. 2003;  180 697-701
  PubMedGoogle Scholar
• 21 Bilchik A J, Wood T F, Allegra D et al.. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.  Arch Surg. 2000;  135 657-662
  PubMedGoogle Scholar
• 22 Onik G, Onik C, Medary I et al.. Life threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation.  AJR Am J Roentgenol. 2003;  181 495-497
  CrossrefPubMedGoogle Scholar
• 23 Bosch F X, Ribes J, Cleries R et al.. Epidemiology of hepatocellular carcinoma.  Clin Liver Dis. 2005;  9 191-211
  CrossrefPubMedGoogle Scholar
• 24 El-Serag H B. Hepatocellular carcinoma: recent trends in the United States.  Gastroenterology. 2004;  127 S27-S34
  CrossrefPubMedGoogle Scholar
• 25 Lencioni R, Cioni D, Crocetti L et al.. Early stage hepatocellular carcinoma in patients with cirrhosis: long term results of percutaneous image-guided radiofrequency ablation.  Radiology. 2005;  234 961-967
  CrossrefPubMedGoogle Scholar
• 26 Livraghi T, Goldberg S N, Lazzaroni S et al.. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions.  Radiology. 2000;  214 761-768
  CrossrefPubMedGoogle Scholar
• 27 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for treatment of hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
  CrossrefPubMedGoogle Scholar
• 28 Ikeda K, Saitoh S, Tsubota A et al.. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.  Cancer. 1993;  71 19-25
  PubMedGoogle Scholar
• 29 Okada S, Shimada K, Yamamoto J et al.. Predictive factors for postoperative recurrence of hepatocellular carcinoma.  Gastroenterology. 1994;  106 1618-1624
  PubMedGoogle Scholar
• 30 Koike Y, Shiratori Y, Sato S et al.. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus: an analysis of 236 consecutive patients with a single lesion.  Hepatology. 2000;  32 1216-1223
  CrossrefPubMedGoogle Scholar
• 31 Lu D S, Yu N C, Raman S S et al.. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.  Radiology. 2005;  234 954-960
  CrossrefPubMedGoogle Scholar
• 32 Lu D S, Yu N C, Raman S S. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.  Hepatology. 2005;  41 1130-1137
  CrossrefPubMedGoogle Scholar
• 33 American Cancer Society .Colorectal Cancer Facts and Figures, Special Edition. Atlanta, GA; American Cancer Society 2005: 1-22
  Google Scholar
• 34 Gillams A R, Lees W R. Radio-frequency ablation of colorectal liver metastases in 167 patients.  Eur Radiol. 2004;  14 2261-2267
  CrossrefPubMedGoogle Scholar
• 35 Hughes K S, Simon R, Songhorabodi S et al.. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.  Surgery. 1986;  100 278-284
  PubMedGoogle Scholar
• 36 Solbiati L, Livraghi T, Goldbert S G et al.. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long term results in 117 patients.  Radiology. 2001;  221 159-166
  CrossrefPubMedGoogle Scholar
• 37 LeVeen R F. Laser hyperthermia and radiofrequency ablation of hepatic lesions.  Semin Intervent Radiol. 1997;  14 313-324
  PubMedGoogle Scholar
• 38 Kemeny N, Huang Y, Cohen A M et al.. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.  N Engl J Med. 1999;  341 2039-2048
  CrossrefPubMedGoogle Scholar
• 39 Bloomston M, Binitie O, Fraiji E et al.. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.  Am Surg. 2002;  68 827-831
  PubMedGoogle Scholar
• 40 Livraghi T, Solbiati L, Meloni F et al.. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection, the “test of time” approach.  Cancer. 2003;  97 3027-3035
  CrossrefPubMedGoogle Scholar
• 41 Gillams A R, Lees W R. RFA of CRC in 167 patients.  Eur Radiol. 2004;  14 2261-2267
  CrossrefPubMedGoogle Scholar
• 42 Fong Y, Cohen A M, Fortner J G et al.. Liver resection for colorectal metastases.  J Clin Oncol. 1997;  15 938-994
  CrossrefPubMedGoogle Scholar
• 43 Oshowo A, Gillams A, Harrison E et al.. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases.  Br J Surg. 2003;  90 1240-1243
  CrossrefPubMedGoogle Scholar
• 44 Berber E, Pelley R, Siperstein A E. Predictors of survival after radiofrequency ablation of colorectal cancer metastasis: a prospective study.  J Clin Oncol. 2005;  23 1358-1364
  CrossrefPubMedGoogle Scholar
• 45 Berber E, Flesher N, Siperstein A E. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.  World J Surg. 2002;  26 985-990
  CrossrefPubMedGoogle Scholar
• 46 Oberg K. The use of chemotherapy in the management of neuroendocrine tumors.  Endocrinol Metab Clin North Am. 1993;  22 941-952
  PubMedGoogle Scholar
• 47 Siperstein A E, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases.  World J Surg. 2001;  25 693-696
  CrossrefPubMedGoogle Scholar
• 48 Siperstein A, Garland A, Engle K et al.. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors: technical considerations.  Surg Endosc. 2000;  14 400-405
  CrossrefPubMedGoogle Scholar
• 49 Elvin A, Skogseid B, Hellman P. Radiofrequency ablation of neuroendocrine liver metastases.  Abdom Imaging. 2005;  30 427-434
  CrossrefPubMedGoogle Scholar
• 50 Elias D, Lasser P H, Montucolli D et al.. Hepatectomy for liver metastases from breast cancer.  Eur J Surg Oncol. 1995;  21 510-523
  CrossrefPubMedGoogle Scholar
• 51 Schneebaum S, Walker M J, Young D et al.. The regional treatment of liver metastases from breast cancer.  J Surg Oncol. 1994;  55 26-31
  PubMedGoogle Scholar
• 52 Livraghi T, Goldbert S N, Solbiati L et al.. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients.  Radiology. 2001;  220 145-149
  PubMedGoogle Scholar
• 53 Burke D R, Lewis C A, Cardella J F et al.. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. Society of Cardiovascular and Interventional Radiology.  J Vasc Interv Radiol. 1997;  8 677-681
  PubMedGoogle Scholar
• 54 Lewis C A, Allen T E, Burke D R et al.. Quality improvement guidelines for central venous access: the Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology.  J Vasc Interv Radiol. 1997;  8 475-479
  PubMedGoogle Scholar
• 55 Fisher R A, Maluf D, Cotterell A H et al.. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.  Clin Transplant. 2004;  18 502-512
  CrossrefPubMedGoogle Scholar
• 56 Curley S A, Marra P, Beaty K et al.. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients.  Ann Surg. 2004;  239 450-458
  CrossrefPubMedGoogle Scholar
• 57 Mulier S, Mulier P, Ni Y et al.. Complications of radiofrequency coagulation of liver tumors.  Br J Surg. 2002;  89 1206-1222
  CrossrefPubMedGoogle Scholar
• 58 Livraghi T, Solbiati L, Meloni M F et al.. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study.  Radiology. 2003;  226 441-451
  CrossrefPubMedGoogle Scholar
• 59 Goldberg S N, Gazelle S G, Mueller P R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques and diagnostic imaging guidance.  AJR Am J Roentgenol. 2000;  174 323-331
  CrossrefPubMedGoogle Scholar
• 60 McGhana J P, Dodd III G D. Radiofrequency ablation of the liver: current status.  AJR Am J Roentgenol. 2001;  176 3-16
  CrossrefPubMedGoogle Scholar
• 61 Dodd III G D, Soulen M, Kane R et al.. Minimally invasive treatment of malignant hepatic tumors: at the threshold of major breakthrough.  Radiographics. 2000;  20 9-27
  PubMedGoogle Scholar
• 62 Gazelle G S, Goldberg S N, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy.  Radiology. 2000;  217 633-646
  CrossrefPubMedGoogle Scholar
• 63 Rossi S, DiStasi M, Buscarini E et al.. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.  AJR Am J Roentgenol. 1996;  167 759-768
  PubMedGoogle Scholar
• 64 Solbiati L, Goldbert S N, Ierace T et al.. Hepatic metastases: percutaneous radiofrequency ablation with cool-tip electrodes.  Radiology. 1997;  205 367-373
  PubMedGoogle Scholar
• 65 Rhim H, Dodd III G D. Radiofrequency thermal ablation of liver tumors.  J Clin Ultrasound. 1999;  27 221-229
  CrossrefPubMedGoogle Scholar

Debra A GervaisM.D. 

Director, Interventional Radiology

Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, White 2 Radiology, Room 270, 55 Fruit Street, Boston, MA 02114